Puma Biotechnology Inc (PBYI) stock is up 14.45% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives PBYI stock a score of 22 out of a possible 100.
That rank is influenced by a short-term technical score of 14. PBYI's rank also includes a fundamental score of 23. In addition to the average rating from Wall Street analysts, PBYI stock has a mean target price of 11. This means analysts expect the stock to rise 0.64% over the next 12 months. The long-term technical score for PBYI is 28.
What's Happening with PBYI Stock Today
Puma Biotechnology Inc (PBYI) stock is lower by -3.7% while the S&P 500 is down -0.27% as of 2:02 PM on Monday, Jun 14. PBYI is down -$0.42 from the previous closing price of $11.35 on volume of 168,391 shares. Over the past year the S&P 500 is higher by 38.13% while PBYI is up 14.45%. PBYI lost -$0.68 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Puma Biotechnology Inc (PBYI) Stock.
